These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2484907)

  • 1. Clinical use of a new pharmaceutical preparation containing L-thyroxine in solution. Preliminary report.
    Carpi A; Toscano S
    Thyroidology; 1989 Apr; 1(1):45-8. PubMed ID: 2484907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term therapy with a new liquid L-thyroxine preparation: bioequivalence with L-T4 tablets.
    Carpi A; Toni MG; Maccheroni M; De Gaudio C
    Thyroidology; 1992 Dec; 4(3):115-9. PubMed ID: 1285037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum levels od D-thyroxine in euthyroidism and hypothyroidism (author's transl)].
    Leb G; Budna KW; Sommersgutter M; Goebel R; Lankmayr EP; Passath A; Knapp G
    Acta Med Austriaca; 1981; 8(3):71-4. PubMed ID: 7270017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioequivalence of L-thyroxine tablets and a liquid L-thyroxine solution in the treatment of hypothyroid patients].
    Grussendorf M; Vaupel R; Wegscheider K
    Med Klin (Munich); 2004 Nov; 99(11):639-44. PubMed ID: 15583873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of replacement and suppressive doses of thyroxine.
    Banovac K; Carrington SA; Levis S; Fill MD; Bilsker MS
    J Int Med Res; 1990; 18(3):210-8. PubMed ID: 2361563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
    Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
    Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
    Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
    Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
    Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: A 2020 THESIS Questionnaire Survey of Members of the Swedish Endocrine Society.
    Planck T; Lantz M; Perros P; Papini E; Attanasio R; Nagy EV; Hegedüs L
    Front Endocrinol (Lausanne); 2021; 12():795111. PubMed ID: 34938274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The associations of polymorphisms of TSH receptor and thyroid hormone receptor genes with L-thyroxine treatment in hypothyroid patients.
    Al-Azzam SI; Alzoubi KH; Khabour O; Al-Azzeh O
    Hormones (Athens); 2014; 13(3):389-97. PubMed ID: 25079464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
    Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
    BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.
    Vita R; Saraceno G; Trimarchi F; Benvenga S
    Endocrine; 2013 Feb; 43(1):154-60. PubMed ID: 22932947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Posologic equivalents of oral L-thyroxine in thyroid insufficiency (120 cases)].
    Ann Med Interne (Paris); 1983; 134(7):636-42. PubMed ID: 6666901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effect of a single oral L-thyroxine dose (150 micrograms) in tablet and in solution on serum thyroxine and TSH concentrations.
    Carpi A; De Gaudio C; Cirigliano G; Toni MG
    Thyroidology; 1993 Apr; 5(1):9-12. PubMed ID: 7508742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low setting of feedback regulation of TSH secretion by thyroxine in pituitary dwarfism with TSH-releasing hormone deficiency.
    Sato T; Ishiguro K; Suzuki Y; Taketani T; Isumisawa A
    J Clin Endocrinol Metab; 1976 Feb; 42(2):385-90. PubMed ID: 816807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.